3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
243
Stomach Neoplasms
23
Breast Neoplasms, Male
16
Neoplasm Metastasis
14
Neoplasms
8
Inflammatory Breast Neoplasms
8
Esophageal Neoplasms
8
Brain Neoplasms
8
Colorectal Neoplasms
6
Adenocarcinoma Of Esophagus
4
Urologic Neoplasms
3
Triple Negative Breast Neoplasms
3
HER2-positive Breast Cancer
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Ductal, Breast
3
Gallbladder Neoplasms
2
Endometrial Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Lobular
2
Carcinoma, Intraductal, Noninfiltrating
2
Biliary Tract Neoplasms
2
Adenocarcinoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Solid Cancers
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Patient Preference
1
Patient Compliance
1
Interventions
Platinum
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Cisplatin
2
Biopsy
2
1,2-diaminocyclohexaneplatinum II citrate
2
rocakinogene sifuplasmid
1
fludarabine phosphate
1
fludarabine
1
durvalumab
1
alovudine
1
aldesleukin
1
Vaccines, Synthetic
1
VGX-3100
1
Sonazoid
1
Respiratory Function Tests
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Prochlorperazine
1
Positron-Emission Tomography
1
Ondansetron
1
O(6)-codeine methyl ether
1
Meperidine
1
Magnetic Resonance Imaging
1
MEDI0457
1
Loperamide
1
Interleukin-2
1
Innovar
1
Indomethacin
1
Immunoglobulin G
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Vulvar Neoplasms
×
Trastuzumab
×
Clear all
No trials found.